Trial Profile
Multicenter study of combination therapy using calcineurin inhibitor, basiliximab, mizoribine and steroids in kidney transplantation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Mizoribine (Primary) ; Basiliximab; Calcineurin inhibitors; Ciclosporin; Steroids; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from recruiting to completed, according to the results published in the International Journal of Urology.
- 31 Aug 2012 New trial record